Pfizer says scaling up manufacturing operations will temporarily impact vaccine shipments in late January to early February

Pfizer makes a statement after having set a new goal of producing 2 billion coronavirus vaccine doses this year, up from the initial 1.3 billion doses
In turn, that will require additional regulatory approvals and thus, impact vaccine shipments in late January to early February. However, the firm says that it will provide a significant increase